Department of Preclinical Development and Validation

Expert reports: Research and development in immune-mediated illnesses

  • Development of novel treatment concepts for chronic inflammatory bowel diseases using non-toxic ligands of the aryl hydrocarbon receptor
  • Development of a novel gene therapy for chronic inflammatory bowel diseases using bacterial vectors
  • Research into the immunological aspects of long COVID
  • Development and validation of special 2D/3D in-vitro (cell lines, organoid models) and in vivo models (e.g., mouse models of dextran sulphate colitis and bacterially induced colitis)